Uncategorized

Lilly deepens relationship with China’s Abbisko for $1.9B biobucks

Published

on

Lilly has already spent more than $25 billion in potential business development commitments this year, including the $6.3 billion buyout of Centessa Pharmaceuticals that closed today.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version